Proinflammatory/profibrotic effects of aldosterone in Gitelman's syndrome, a human model opposite to hypertension

被引:2
|
作者
Ravarotto, V [1 ]
Simioni, F. [1 ]
Sabbadin, C. [2 ]
Pagnin, E. [1 ]
Maiolino, G. [3 ]
Armanini, D. [2 ]
Calo, L. A. [1 ]
机构
[1] Univ Padua, Dept Med Nephrol, Via Giustiniani 2, I-35128 Padua, Italy
[2] Univ Padua, Dept Med Endocrinol, Padua, Italy
[3] Univ Padua, Dept Med Hypertens, Padua, Italy
关键词
Gitelman's syndrome; Aldosterone; Angiotensin II; Oxidative stress; Mononuclear leucocytes; Rho kinase; MINERALOCORTICOID RECEPTOR; OXIDATIVE STRESS; ANGIOTENSIN-II; SMOOTH-MUSCLE; EPLERENONE; POTASSIUM; DISEASE; BLOCKER; SERUM;
D O I
10.1007/s40618-018-0942-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeAldosterone proinflammatory/profibrotic effects are mediated by the induction of mononuclear leucocytes (MNL) to express oxidative stress (OxSt)-related proteins, such as p22(phox), and by the activation of RhoA/Rho kinase pathway. Gitelman's syndrome (GS), an autosomal recessive tubulopathy, is an interesting opposite model to hypertension, being characterized by hypokalemia, activation of renin-angiotensin-aldosterone system yet normo/hypotension and lack of cardiovascular-renal remodeling. We aimed to evaluate the proinflammatory/profibrotic effect of aldosterone in MNL of 6 GS patients compared with 6 healthy subjects (HS).Methodsp22(phox) expression and MYPT-1 phosphorylation status, a marker of RhoA/Rho kinase pathway activation, were evaluated in MNL of GS patients and HS at baseline and after incubation with aldosterone (1x10(-8)M) alone or with canrenone (1x10(-6)M).ResultsAt basal condition, p22(phox) expression was significantly higher in HS than in GS patients (1.020.05densitometric unit (du) vs 0.40 +/- 0.1du, respectively). Aldosterone significantly increased p22(phox) expression in HS and this effect was reversed by coincubation with canrenone (1.4 +/- 0.05du and 1.09 +/- 0.03du, respectively). No significant change was reported in GS after incubation of MNL with aldosterone and/or canrenone compared with basaline. Even MYPT-1 phosphorylation was significantly higher in HS compared with GS patients at basal condition (1.16 +/- 0.1du vs 0.69 +/- 0.07, respectively). Aldosterone significantly increased MYPT-1 phosphorylation only in HS (1.37 +/- 0.1du vs 0.83 +/- 0.12du in GS).Conclusions p id=Par4 GS patients seem to be protected by the OxSt status induced by aldosterone and revealed in HS. This human model could provide additional clues to highlight the proinflammatory/cardiovascular remodeling effects of aldosterone.
引用
收藏
页码:521 / 526
页数:6
相关论文
共 50 条
  • [1] Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension
    V. Ravarotto
    F. Simioni
    C. Sabbadin
    E. Pagnin
    G. Maiolino
    D. Armanini
    L. A. Calò
    Journal of Endocrinological Investigation, 2019, 42 : 521 - 526
  • [2] MOLECULAR EVIDENCE FOR THE PROINFLAMMATORY/PROFIBROTIC AND CARDIOVASCULAR REMODELING EFFECTS OF ALDOSTERONE: INSIGHTS FROM GITELMAN SYNDROME, A HUMAN MODEL OPPOSITE TO HYPERTENSION
    Ravarotto, V.
    Pagnin, E.
    Sabbadin, C.
    Armanini, D.
    Calo, L. A.
    JOURNAL OF HYPERTENSION, 2017, 35 : E2 - E2
  • [3] Hypertension in a patient with Gitelman's syndrome
    Ogihara, T
    Katsuya, T
    Ishikawa, K
    Matsuo, A
    Rakugi, H
    Shoji, M
    Yasujima, M
    JOURNAL OF HUMAN HYPERTENSION, 2004, 18 (09) : 677 - 679
  • [4] Hypertension in a patient with Gitelman's syndrome
    T Ogihara
    T Katsuya
    K Ishikawa
    A Matsuo
    H Rakugi
    M Shoji
    M Yasujima
    Journal of Human Hypertension, 2004, 18 : 677 - 679
  • [5] Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter’s and Gitelman’s syndromes
    L. A. Calò
    G. Maiolino
    Journal of Endocrinological Investigation, 2015, 38 : 711 - 716
  • [6] Mechanistic approach to the pathophysiology of target organ damage in hypertension from studies in a human model with characteristics opposite to hypertension: Bartter's and Gitelman's syndromes
    Calo, L. A.
    Maiolino, G.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2015, 38 (07) : 711 - 716
  • [7] Angiotensin II signalling in Bartter's and Gitelman's syndromes: A negative human model of hypertension
    Calò L.A.
    Pessina A.C.
    Semplicini A.
    High Blood Pressure & Cardiovascular Prevention, 2005, 12 (1) : 17 - 26
  • [8] Angiotensin II Signalling in Bartter's and Gitelman's Syndromes A Negative Human Model of Hypertension
    Calo, Lorenzo A.
    Pessina, Achille C.
    Semplicini, Andrea
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2005, 12 (01) : 17 - 26
  • [9] Hypokalemia in a mouse model of Gitelman's syndrome
    Morris, RG
    Hoorn, EJ
    Knepper, MA
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2006, 290 (06) : F1416 - F1420
  • [10] Proinflammatory/Profibrotic Effects of Interleukin-17A on Human Proximal Tubule Epithelium
    Dudas, Paul L.
    Sague, Sarah L.
    Elloso, M. Merle
    Farrell, Francis X.
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2011, 117 (04): : E114 - E123